4//SEC Filing
Schnee Elmar 4
Accession 0001232524-17-000150
CIK 0001232524other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 5:29 PM ET
Size
11.7 KB
Accession
0001232524-17-000150
Insider Transaction Report
Form 4
Schnee Elmar
Director
Transactions
- Award
Ordinary Shares
2017-08-10+1,365→ 6,540 total - Sale
Ordinary Shares
2017-08-11$142.36/sh−1,194$169,978→ 5,346 total - Sale
Ordinary Shares
2017-08-11$144.20/sh−3$433→ 5,343 total - Sale
Ordinary Shares
2017-08-11$144.13/sh−2$288→ 5,341 total - Award
Non-Qualified Stock Option (right to buy)
2017-08-10+3,415→ 3,415 totalExercise: $143.66Exp: 2027-08-09→ Ordinary Shares (3,415 underlying)
Footnotes (3)
- [F1]These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2018.
- [F2]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F3]These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2017.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001615762
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 5:29 PM ET
- Size
- 11.7 KB